Heart Attack (Myocardial Infarction) News and Research

RSS

A Heart Attack (Myocardial Infarction) occurs when blood flow to a section of heart muscle becomes blocked. If the flow of blood isn’t restored quickly, the section of heart muscle becomes damaged from lack of oxygen and begins to die.

Heart attack is a leading killer of both men and women in the United States. But fortunately, today there are excellent treatments for heart attack that can save lives and prevent disabilities. Treatment is most effective when started within 1 hour of the beginning of symptoms. Heart attacks occur most often as a result of a condition called coronary artery disease (CAD). In CAD, a fatty material called plaque (plak) builds up over many years on the inside walls of the coronary arteries (the arteries that supply blood and oxygen to your heart). Eventually, an area of plaque can rupture, causing a blood clot to form on the surface of the plaque. If the clot becomes large enough, it can mostly or completely block the flow of oxygen-rich blood to the part of the heart muscle fed by the artery.

Nuts added to unhealthy diets can still reduce cholesterol and benefit the heart

It has been known for a while now that eating nuts regularly offers cardiovascular benefits. Now a new study has established the fact that a regular intake of nuts can lead to better and healthier cholesterol levels.

10 May 2010

Forbidding ambulance costs deter heart attack victims from calling ‘000’: National Heart Foundation

According to a new survey conducted by The National Heart Foundation, the forbidding ambulance costs are preventing timely calls to the emergency by at least one in 10 heart attack victims. The Foundation also released a discussion paper released during Heart Week urging free universal ambulance services in all states and territories. Dr Bill Coote in the paper entitled Universal Ambulance Cover has also said that this would prevent many heart attack deaths.

5 May 2010

Mandatory cuts for salt content in processed foods on the horizon

This Tuesday The Institute of Medicine (IOM) has urged the US Food and Drug Administration to start regulating the amount of salt in processed foods. This measure according to them can do what years of advising people to cut down on salt have failed to do.

22 Apr 2010

Trans fats back on the agenda in UK

Dariush Mozzaffarian and Meir J Stamper, wrote an article in the British Medical Journal urging the government to ban industrial trans fatty acids or TFAs. This adds to the plea of doctors and medical charities across the country, who want to follow the example of Denmark and New York City where TFAs have been eradicated without affecting the price, taste or availability of products.

19 Apr 2010

Insurance status and heart attack, many patients not seeking needed help

The signs of a cardiac arrest may exist but if you are under insured or not insured there is good chance that you may not undertake the recommended life saving actions of getting professional help as soon as you can.

14 Apr 2010

Blood levels of carbon dioxide may be linked to near death experiences after heart attack

Near death experiences have often been described as “seeing life flash before one’s eyes” or “intense feelings of joy and peace.” Now researchers claim that levels of Carbon Dioxide or CO2 may be the causal link for these sensations. They believe that the CO2 alters the levels of certain chemicals in the brain and makes it see lights at the ends of tunnels or dead loved ones.

9 Apr 2010

Gene therapy improve survival rates among heart attack patients

Gene therapy could be an effective way to improve survival rates among heart attack patients, new research funded by the British Heart Foundation (BHF) suggests. Academics at the University of Bristol found that boosting levels of a natural growth factor in the heart could help the muscle to recover after a heart attack. The death rate from a heart attack was halved in mice that received the treatment.

1 Apr 2010

Valsartan delays progression to type 2 diabetes in IGT patients: NAVIGATOR study

Results from a landmark study involving more than 9,000 people showed that the high blood pressure medicine valsartan delayed progression to type 2 diabetes in patients with cardiovascular disease or risk factors and impaired glucose tolerance (IGT), a common pre-diabetic condition.

15 Mar 2010

New fatigue rating scale predicts increased risk of heart attack in dialysis patients

For dialysis patients, high scores on a new fatigue rating scale predict an increased risk of heart attack or other cardiovascular events, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology.

25 Feb 2010

Sulphonylureas, an antidiabetic drug, carries greater risk of heart failure and death compared to metformin

Research: Risk of cardiovascular disease and all cause mortality among patients with type 2 diabetes prescribed oral antidiabetes drugs: Retrospective cohort study using UK general practice research database

4 Dec 2009

Sudden cardiac death more predictable in men than women

A woman who suffers sudden cardiac arrest is significantly less likely than a man to exhibit the decrease in the heart's pumping ability that is widely recognized as a precursor, says a new study in the Nov. 24 Journal of the American College of Cardiology.

17 Nov 2009

COMPARE trial results demonstrate higher efficacy of XIENCE V stent system

Late-breaking data presented today from the COMPARE trial demonstrated that Abbott's market-leading XIENCE V(R) Everolimus Eluting Coronary Stent System demonstrated significantly better outcomes in key safety and efficacy measures compared to the TAXUS(R) Liberte Paclitaxel-Eluting Coronary Stent System (TAXUS).

24 Sep 2009

New critical illness plan from Colonial Life introduced

A new critical illness plan from Colonial Life & Accident Insurance Company can help many working Americans who may be one serious medical issue away from financial problems. Even with good health insurance, a serious illness, such as a heart attack or stroke, could leave employees on the hook for huge expenses.

15 Sep 2009

Study reveals elevated cTnT levels in post-CABG patients

Levels of a biomarker used in the diagnosis of heart attacks are almost universally elevated in patients who have undergone coronary-artery bypass grafting (CABG) and, when markedly elevated, are powerfully prognostic, a team of researchers from the Massachusetts General Hospital (MGH) Heart Center has found.

5 Sep 2009

Abbott introduces XIENCE PRIME Everolimus Eluting Coronary Stent System for global market

Abbott (NYSE: ABT) today announced at the European Society of Cardiology Congress the widespread availability of its next-generation XIENCE PRIME(TM) Everolimus Eluting Coronary Stent System for the treatment of coronary artery disease.

31 Aug 2009

Patients enrolled in the TREAT Phase 3 study treated with Aranesp to a target hemoglobin of 13 g/dL

Amgen today announced that in a large, randomized, double-blind, placebo-controlled, Phase 3 study of patients with chronic kidney disease (CKD) (not requiring dialysis), anemia and type-2 diabetes (the Trial to Reduce Cardiovascular Endpoints with Aranesp((R)) Therapy, or TREAT), treatment of anemia with Aranesp((R) )(darbepoetin alfa) to a hemoglobin target of 13 g/dL had no statistically significant effect on either of two primary endpoints compared with placebo treatment.

26 Aug 2009

Heart Attack (Myocardial Infarction) News and Research

Further Reading

Nuts added to unhealthy diets can still reduce cholesterol and benefit the heart

Forbidding ambulance costs deter heart attack victims from calling ‘000’: National Heart Foundation

Mandatory cuts for salt content in processed foods on the horizon

Trans fats back on the agenda in UK

Insurance status and heart attack, many patients not seeking needed help

Blood levels of carbon dioxide may be linked to near death experiences after heart attack

Gene therapy improve survival rates among heart attack patients

Valsartan delays progression to type 2 diabetes in IGT patients: NAVIGATOR study

New fatigue rating scale predicts increased risk of heart attack in dialysis patients

Sulphonylureas, an antidiabetic drug, carries greater risk of heart failure and death compared to metformin

Sudden cardiac death more predictable in men than women

COMPARE trial results demonstrate higher efficacy of XIENCE V stent system

New critical illness plan from Colonial Life introduced

Study reveals elevated cTnT levels in post-CABG patients

Abbott introduces XIENCE PRIME Everolimus Eluting Coronary Stent System for global market

Patients enrolled in the TREAT Phase 3 study treated with Aranesp to a target hemoglobin of 13 g/dL

Emergency physicians should trust their judgment on chest pain symptoms

Tiny device to 'sniff out' disease, heart attacks, poison and environmental pollution

New chemical imaging technique could help in the fight against atherosclerosis

New drug promises to reduce damage from a heart attack

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News